HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer.

Abstract
The two membrane-bound proteins, focal adhesion kinase (FAK) and CD44, are involved in processes critical to cancer progression. FAK has an active role in angiogenesis, cell proliferation and cell apoptosis, whereas the heavily glycosylated CD44 has been implicated in cancer metastasis. Here, using short hairpin RNA (shRNA) against FAK and CD44, we demonstrate that simultaneous knockdown of both these genes inhibits cancer growth more efficiently than knockdown of either gene individually. Plasmids targeting these genes or non-relative control sequences were constructed and delivered to ovarian cancer targets by biodegradable poly D,L-lactide-co-glycolide acid nanoparticles (PLGANPs). Nude mice were utilized in an intraperitoneal model of ovarian carcinomatosis to assess antitumor efficacy in vivo. Single gene knockdown resulted in significantly smaller tumors than those observed in the empty-vector control (P's<0.001). More importantly, knockdown of both genes resulted in tumors smaller than both the empty-vector group (P<0.0001) and the single gene knockdown groups (P's<0.001). Knockdown of both FAK and CD44 resulted in tumors with inhibited angiogenesis, reduced proliferation and increased apoptosis as compared with controls (P's<0.001) and single knockdown groups (P's<0.05). These results indicate that dual knockdown of FAK and CD44 in the tumors of patients with ovarian cancer may have an enhanced therapeutic effect, and point toward a mechanism involving the inhibition of angiogenesis, cellular proliferation and the induction of apoptosis.
AuthorsL Zou, X Song, T Yi, S Li, H Deng, X Chen, Z Li, Y Bai, Q Zhong, Y Wei, X Zhao
JournalCancer gene therapy (Cancer Gene Ther) Vol. 20 Issue 4 Pg. 242-50 (Apr 2013) ISSN: 1476-5500 [Electronic] England
PMID23492823 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CD44 protein, human
  • Hyaluronan Receptors
  • RNA, Small Interfering
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Focal Adhesion Protein-Tyrosine Kinases
Topics
  • Animals
  • Apoptosis
  • Cell Proliferation
  • Female
  • Focal Adhesion Protein-Tyrosine Kinases (genetics, metabolism)
  • Gene Knockdown Techniques
  • Genetic Therapy
  • Humans
  • Hyaluronan Receptors (genetics, metabolism)
  • Lactic Acid (chemistry)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Nanoparticles (chemistry)
  • Neoplasm Transplantation
  • Neovascularization, Pathologic (therapy)
  • Ovarian Neoplasms (blood supply, pathology, therapy)
  • Polyglycolic Acid (chemistry)
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • RNA Interference
  • RNA, Small Interfering (genetics)
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: